Skip to content

   Pharma Publications

Neuropsychopharmacology
  • White and gray matter alterations in bipolar I and bipolar II disorder subtypes compared with healthy controls – exploring associations with disease course and polygenic risk
    Published on 2024-02-07
    2 years ago
  • Two polygenic mouse models of major depressive disorders identify TMEM161B as a potential biomarker of disease in humans
    Published on 2024-02-06
    2 years ago
  • Stress integration by an ascending adrenergic-melanocortin circuit
    Published on 2024-02-06
    2 years ago
  • Brain connectivity changes to fast versus slow dopamine increases
    Published on 2024-02-06
    2 years ago
  • Network-based drug repurposing for schizophrenia
    Published on 2024-02-05
    2 years ago
  • Identifying novel proteins for suicide attempt by integrating proteomes from brain and blood with genome-wide association data
    Published on 2024-02-04
    2 years ago
  • Heartbeat-evoked neural response abnormalities in generalized anxiety disorder during peripheral adrenergic stimulation
    Published on 2024-01-29
    2 years ago
« Previous 1 … 90 91 92 93 94 … 143 Next »
Journal of Psychopharmacology
  • 5-HT1B receptor agonist attenuates cocaine self-administration after protracted abstinence and relapse in rats
    Published on 2021-05-29
    5 years ago
  • Assessment of cognitive and psychomotor impairment, subjective effects, and blood THC concentrations following acute administration of oral and vaporized cannabis
    Published on 2021-05-29
    5 years ago
  • Unravelling cases of clozapine-related Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) in patients reported otherwise: A systematic review
    Published on 2021-05-28
    5 years ago
  • ‘Memory, hither come’: Psychopharmacology of memory and more
    Published on 2021-05-27
    5 years ago
  • Altered cerebellar-cortical resting-state functional connectivity in cannabis users
    Published on 2021-05-26
    5 years ago
  • Sustained NMDA receptor hypofunction impairs brain-derived neurotropic factor signalling in the PFC, but not in the hippocampus, and disturbs PFC-dependent cognition in mice
    Published on 2021-05-19
    5 years ago
  • The epidemiology of mescaline use: Pattern of use, motivations for consumption, and perceived consequences, benefits, and acute and enduring subjective effects
    Published on 2021-05-05
    5 years ago
« Previous 1 … 90 91 92 93 94 … 145 Next »
European Neuropsychopharmacology
  • The Burden of schizophrenia
    Published on 2022-01-11
    4 years ago
  • Guanosine boosts the fast, but not sustained, antidepressant-like and pro-synaptogenic effects of ketamine by stimulating mTORC1-driven signaling pathway
    Published on 2022-01-08
    4 years ago
  • Neuropeptide Y, calcitonin gene-related peptide, and neurokinin A in brain regions of HAB rats correlate with anxiety-like behaviours
    Published on 2022-01-08
    4 years ago
  • Metabolomics changes after rTMS intervention reveal potential peripheral biomarkers in methamphetamine dependence
    Published on 2022-01-04
    4 years ago
  • When depression is difficult to treat
    Published on 2022-01-04
    4 years ago
  • Corrigendum to “Chronic exposure to glucocorticoids induces suboptimal decision-making in mice” [Volume 46, May 2021, Pages 56-67]
    Published on 2021-12-22
    4 years ago
  • Corrigendum to “Modelling decision-making under uncertainty: A direct comparison study between human and mouse gambling data” [31, February 2020, Pages  58–68]
    Published on 2021-12-22
    4 years ago
« Previous 1 … 90 91 92 93 94 … 166 Next »

   Pharma Pub